Alector, Inc. — Investor Relations & Filings
Filings indexed
558
across all filing types
Latest filing
2026-05-07
Regulatory Filings
Country
US
United States of America
Listing
US
ALEC
Alector, Inc. is a clinical-stage biotechnology company that develops therapies for neurodegenerative diseases. The company pioneers an approach known as immuno-neurology, which utilizes the body's immune system to address brain disorders. By integrating insights from human genetics, neuroscience, and immunology, Alector is advancing a pipeline of potential first-in-class and best-in-class medicines. Its therapeutic candidates are designed to treat conditions such as Alzheimer's disease and frontotemporal dementia by removing toxic proteins, replacing deficient proteins, and restoring the function of immune and nerve cells. The company's primary mission is to slow the progression of neurodegenerative diseases and improve overall brain health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | |
| 424B5 - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | |
| SCHEDULE 13G/A - Alector, Inc. (0001653087) (Subject) | 2026-03-26 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | |
| 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 43582544 | 8-K - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | ||
| 43582400 | 424B5 - Alector, Inc. (0001653087) (Filer) | 2026-05-07 | English | ||
| 33051721 | SCHEDULE 13G/A - Alector, Inc. (0001653087) (Subject) | 2026-03-26 | English | ||
| 32895933 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895934 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895935 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895936 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-03-03 | English | ||
| 32895937 | 4 - ALECTOR, INC. (0001653087) (Filer) | 2026-02-26 | English | ||
| 32895939 | 10-K - ALECTOR, INC. (0001653087) (Filer) | 2026-02-25 | English | ||
| 32895938 | 8-K - ALECTOR, INC. (0001653087) (Filer) | 2026-02-25 | English | ||
| 31149185 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 31149162 | SCHEDULE 13G/A Filing | 2026-02-06 | English | ||
| 31149204 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
|
2025
2 filings
| |||||
| 12908328 | 8-K | 2025-12-12 | English | ||
| 12908333 | Director's Dealing 2025 | 2025-12-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ECO ANIMAL HEALTH GROUP PLC
Develops and markets pharmaceuticals and biologicals for pi…
|
EAH | GB | Manufacturing |
|
Edesa Biotech, Inc.
Clinical-stage biopharma developing therapies for inflammat…
|
EDSA | US | Manufacturing |
|
Edgewise Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for rare m…
|
EWTX | US | Manufacturing |
|
Egetis Therapeutics
Develops and commercializes treatments for serious and rare…
|
EGTX | SE | Manufacturing |
|
EIKEN CHEMICAL CO.,LTD.
Manufacturer of clinical diagnostics, medical equipment, an…
|
4549 | JP | Manufacturing |
|
EirGenix, Inc.
Integrates CDMO services with proprietary biosimilar and ca…
|
6589 | TW | Manufacturing |
|
Eisai Co., Ltd.
A research-based pharmaceutical company focused on neurolog…
|
4523 | JP | Manufacturing |
|
Elanco Animal Health Inc
Develops products and services to prevent and treat disease…
|
ELAN | US | Manufacturing |
|
Elanix Biotechnologies AG
Develops products from progenitor cells for wound care and …
|
ELN | DE | Manufacturing |
|
ELI LILLY & Co
A research-based company that develops and sells pharmaceut…
|
LLY | US | Manufacturing |
Alector, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33290/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33290 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33290 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33290 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33290}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Alector, Inc. (id: 33290)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.